ES2172572T3 - Emulsion farmaceutica. - Google Patents

Emulsion farmaceutica.

Info

Publication number
ES2172572T3
ES2172572T3 ES95900965T ES95900965T ES2172572T3 ES 2172572 T3 ES2172572 T3 ES 2172572T3 ES 95900965 T ES95900965 T ES 95900965T ES 95900965 T ES95900965 T ES 95900965T ES 2172572 T3 ES2172572 T3 ES 2172572T3
Authority
ES
Spain
Prior art keywords
pct
pharmaceutical emulsion
date
sec
pub
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95900965T
Other languages
English (en)
Inventor
Kjell Hjalmar Andersson
Eva Kristina Byrod
Anna-Carin Hansson
Margareta Nordlander
Rolf Christer Westerlund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of ES2172572T3 publication Critical patent/ES2172572T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA EMULSION FARMACEUTICA QUE CONTIENE (A) UN COMPUESTO DE DIHIDROPIRIDINA DE ACTUACION RAPIDA; (B) UNA FASE LIPIDA; (C) UN EMULSOR; Y (D) AGUA O UN TAMPON, AL USO DE Y AL PROCEDIMIENTO PARA LA PREPARACION DE LA EMULSION.
ES95900965T 1993-11-12 1994-11-03 Emulsion farmaceutica. Expired - Lifetime ES2172572T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303744A SE9303744D0 (sv) 1993-11-12 1993-11-12 Pharmaceutical emulsion

Publications (1)

Publication Number Publication Date
ES2172572T3 true ES2172572T3 (es) 2002-10-01

Family

ID=20391731

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95900965T Expired - Lifetime ES2172572T3 (es) 1993-11-12 1994-11-03 Emulsion farmaceutica.

Country Status (31)

Country Link
US (1) US5739152A (es)
EP (1) EP0727997B1 (es)
JP (1) JP3759951B2 (es)
KR (1) KR100345627B1 (es)
CN (1) CN1072934C (es)
AT (1) ATE213158T1 (es)
AU (1) AU678650B2 (es)
CA (1) CA2176360C (es)
CZ (1) CZ290772B6 (es)
DE (1) DE69429871T2 (es)
DK (1) DK0727997T3 (es)
EE (1) EE03223B1 (es)
EG (1) EG20764A (es)
ES (1) ES2172572T3 (es)
FI (1) FI116999B (es)
HK (1) HK1013261A1 (es)
HU (1) HU223142B1 (es)
IL (1) IL111345A (es)
IS (1) IS2036B (es)
MY (1) MY121201A (es)
NO (1) NO314877B1 (es)
NZ (1) NZ276197A (es)
PL (1) PL181462B1 (es)
PT (1) PT727997E (es)
RU (1) RU2144358C1 (es)
SA (1) SA94150314B1 (es)
SE (1) SE9303744D0 (es)
SK (1) SK283271B6 (es)
UA (1) UA40633C2 (es)
WO (1) WO1995013066A1 (es)
ZA (1) ZA948180B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030158220A1 (en) * 1997-11-03 2003-08-21 Foss Joseph F. Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
ATE259220T1 (de) * 1998-05-29 2004-02-15 Skyepharma Canada Inc Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
SE9804002D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New manufacturing process
DE10036871A1 (de) 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
WO2002102311A2 (en) 2001-06-15 2002-12-27 Cornerstone Pharmaceuticals Nanoparticles for treating targeted tissues and cells
PL2368553T3 (pl) * 2003-04-08 2015-05-29 Progenics Pharm Inc Preparaty farmaceutyczne zawierające metylonaltrekson
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
TW200817048A (en) * 2006-09-08 2008-04-16 Wyeth Corp Dry powder compound formulations and uses thereof
AU2008233129B2 (en) * 2007-03-29 2014-03-20 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
ES2540551T3 (es) * 2007-03-29 2015-07-10 Wyeth Llc Antagonistas de receptores opioides periféricos y usos de los mismos
JP2010522756A (ja) 2007-03-29 2010-07-08 プロジェニックス ファーマシューティカルズ，インコーポレーテッド 結晶形およびその使用
CN101959892B (zh) * 2008-02-06 2014-01-08 普罗热尼奇制药公司 (r),(r)-2,2’-二-甲基纳曲酮的制备和用途
AU2009276560B2 (en) 2008-08-01 2015-04-16 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions and methods for producing low impurity concentrations of the same
SI2320739T1 (sl) 2008-08-01 2020-03-31 Chiesi Farmaceutici S.P.A. Farmacevtski sestavki in postopki za njihovo stabiliziranje
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US9034389B2 (en) * 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
WO2010107081A1 (ja) * 2009-03-19 2010-09-23 第一三共株式会社 包装により安定保存された固形製剤
CN101780036B (zh) * 2010-03-30 2011-11-16 武汉武药科技有限公司 丁酸氯维地平脂微球注射液及其制备方法
US8658676B2 (en) * 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
AU2011313852B2 (en) 2010-10-12 2015-07-02 Chiesi Farmaceutici S.P.A. Clevidipine emulsion formulations containing antimicrobial agents
CN102531998A (zh) * 2010-12-09 2012-07-04 天津药物研究院 α型多晶型丁酸氯维地平结晶、其制备方法、用途和药物组合物
CN102525918A (zh) * 2010-12-30 2012-07-04 天津药物研究院 一种丁酸氯维地平的脂肪乳注射液及其制备工艺
US20120213855A1 (en) * 2011-02-17 2012-08-23 Cima Labs Inc. Dosage forms for weakly ionizable compounds
RU2623039C2 (ru) * 2011-04-01 2017-06-21 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Дигидропиридины (клевидипин) кратковременного действия для применения в восстановлении после инсульта
KR102009698B1 (ko) 2011-12-20 2019-08-13 바이옴 테라퓨틱스 리미티드 진균 감염의 치료를 위한 국소 오일 조성물
JP6329957B2 (ja) 2012-10-26 2018-05-23 キエージィ ファーマチェウティチ エス．ペー．アー． 心不全において血圧を制御するためおよび呼吸困難を低減させるための方法
CN103110580B (zh) * 2013-02-20 2014-09-17 北京德立福瑞医药科技有限公司 丁酸氯维地平注射剂
EA201591954A1 (ru) * 2013-04-12 2016-04-29 Вайом Байосайнсиз Пвт. Лтд. Композиция и состав противомикробных средств, способы их получения и способы лечения микробных инфекций
RU2759673C2 (ru) 2014-05-19 2021-11-16 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Наночастицы клевидипина и их фармацевтические композиции

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315805A1 (de) * 1983-04-30 1984-11-08 Bayer Ag, 5090 Leverkusen Wirkstoffzubereitungen
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
DE3515335C2 (de) * 1985-04-27 1995-01-26 Bayer Ag Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
DE4217842A1 (de) * 1992-05-29 1993-12-02 Dietl Hans Calciumantagonisten enthaltende pharmazeutische Zubereitung zur intravenösen und intrakoronaren Applikation sowie Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
AU1037195A (en) 1995-05-29
IL111345A0 (en) 1994-12-29
CN1136774A (zh) 1996-11-27
NO961898L (no) 1996-06-25
CZ133896A3 (en) 1996-09-11
HU223142B1 (hu) 2004-03-29
SK283271B6 (sk) 2003-04-01
US5739152A (en) 1998-04-14
SE9303744D0 (sv) 1993-11-12
AU678650B2 (en) 1997-06-05
DE69429871T2 (de) 2002-08-22
ATE213158T1 (de) 2002-02-15
ZA948180B (en) 1995-05-12
FI961999A (fi) 1996-05-10
NO961898D0 (no) 1996-05-10
PL181462B1 (pl) 2001-07-31
DE69429871D1 (de) 2002-03-21
FI961999A0 (fi) 1996-05-10
PT727997E (pt) 2002-07-31
RU2144358C1 (ru) 2000-01-20
EP0727997A1 (en) 1996-08-28
SK59796A3 (en) 1996-12-04
DK0727997T3 (da) 2002-04-22
NZ276197A (en) 1997-04-24
NO314877B1 (no) 2003-06-10
HUT74474A (en) 1996-12-30
EG20764A (en) 2000-01-31
CA2176360A1 (en) 1995-05-18
HK1013261A1 (en) 1999-08-20
IS2036B (is) 2005-08-15
IS4224A (is) 1995-05-13
KR100345627B1 (ko) 2003-03-15
PL314263A1 (en) 1996-09-02
JPH09505045A (ja) 1997-05-20
CZ290772B6 (cs) 2002-10-16
SA94150314B1 (ar) 2005-06-14
MY121201A (en) 2006-01-28
IL111345A (en) 2000-08-31
JP3759951B2 (ja) 2006-03-29
EE03223B1 (et) 1999-10-15
EP0727997B1 (en) 2002-02-13
CN1072934C (zh) 2001-10-17
UA40633C2 (uk) 2001-08-15
HU9601268D0 (en) 1996-07-29
CA2176360C (en) 2005-08-23
FI116999B (fi) 2006-05-15
WO1995013066A1 (en) 1995-05-18

Similar Documents

Publication Publication Date Title
DK0727997T3 (da) Farmaceutisk emulsion
FI970858A0 (fi) Tirilasadin parenteraalinen apuliuotinformulaatio
NO973730D0 (no) Faste virkestofftilberedninger
ATE195117T1 (de) 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren
ES2145158T3 (es) Nueva formulacion de emulsion.
PT692028E (pt) Farmacos baseados em papilomavirus
ES2172600T3 (es) Composicion farmaceutica que comprende lamotrigina.
SE8600632D0 (sv) Novel pharmaceutical composition
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
SE9401596D0 (sv) New compounds
DK0850225T3 (da) Mellemprodukt til fremstilling af en farmaceutisk aktiv forbindelse
SE9501773D0 (sv) New use

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 727997

Country of ref document: ES